Position in INSM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$242,370,927
-$185,601,953 QoQ
Shares Held
2,273,222
-13.1% QoQ
Ownership
1.04%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#21
of 663 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. INSM ranks #6 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
This page
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in INSM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $242,370,927 | 2,273,222 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $427,972,880 | 2,617,251 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $479,573,482 | 2,755,536 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $308,141,793 | 2,139,725 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $236,517,383 | 2,350,133 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $163,892,584 | 2,148,284 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $149,133,509 | 2,160,103 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $198,661,397 | 2,721,389 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $182,125,430 | 2,718,290 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $96,773,061 | 3,567,013 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $105,264,569 | 3,396,727 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $86,148,884 | 3,411,837 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $72,449,803 | 3,433,640 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $59,797,350 | 3,507,176 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $70,057,312 | 3,506,372 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $75,657,914 | 3,512,438 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $69,045,458 | 3,501,291 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $78,271,073 | 3,330,684 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $90,659,269 | 3,328,167 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $94,952,081 | 3,447,788 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $98,152,335 | 3,448,782 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $96,545,965 | 2,834,585 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $93,035,729 | 2,794,705 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $93,414,395 | 2,906,484 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $74,746,038 | 2,714,090 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $31,893,047 | 1,989,585 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||